CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Roflumilast
Brand Name: Daxas
Manufacturer: Nycomed Canada Inc.
Indications: Chronic obstructive pulmonary disease (COPD)
Submission Type: New
Project Status: Complete
Date Recommendation Issued: July 27, 2011
Recommendation Type: Do not list
